Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 10, 2000, Pages 1121-1131

  McCann, S M ^a   Antunes Rodrigues, J ^b   Franci, C R ^b   Anselmo Franci, J A ^b   Karanth, S ^a   Rettori, V ^c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Acetyl choline; ACTH; Atrial natriuretic peptide (ANP); Corticotropin releasing hormone (CRH); Cortisol; Nitric oxide; Norepinephrine; Oxytocin; Vasopressin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; LIPOPOLYSACCHARIDE; NITRIC OXIDE; OXYTOCIN; VASOPRESSIN DERIVATIVE;

ANIMAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGY; REVIEW; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTIONS; CORTICOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPOPOLYSACCHARIDES; NITRIC OXIDE; OXYTOCIN; PITUITARY-ADRENAL SYSTEM; STRESS; VASOPRESSINS;

EID: 0034293122     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000001000001     Document Type: Article

References (47)

1. McCann SM (1988). Saga of the discovery of the hypothalamic releasing and inhibiting hormones. In: McCann SM (Editor), People and Ideas in Endocrinology. American Physiological Society, Bethesda, MD, 41-62.
2. McCann SM (1999). Hypothalamic releasing and inhibiting hormones. In: Adelman G & Smith BH (Editors), Encyclopedia of Neuroscience. Elsevier, New York, 927-930.
3. McCann SM & Brobeck JR (1954). Evidence for a role of the supraopticohypophyseal system in regulation of adrenocorticotrophin secretion. Proceedings of the Society for Experimental Biology and Medicine, 87: 318-324.
4. McCann SM & Fruit A (1957). Effect of synthetic vasopressin on release of adrenocorticotrophin in rats with hypothalamic lesions. Proceedings of the Society for Experimental Biology and Medicine, 96: 556-567.
5. Saffran M & Schally AV (1955). Release of corticotrophin by anterior pituitary tissue in vitro Canadian Journal of Biochemistry and Physiology, 33: 408-415.
6. Guillemin R & Hearn WR (1955). ACTH release by in vitro pituitary: effect of Pitressin and purified arginine vasopressin. Proceedings of the Society for Experimental Biology and Medicine, 89: 365-367.
7. McCann SM (1957). The ACTH-releasing activity of extracts of the posterior lobe of the pituitary in vivo. Endocrinology, 60: 664-676.
8. McCann SM & Porter JC (1969). Hypothalamic pituitary stimulating and inhibiting hormones. Physiological Reviews, 49: 240-283.
9. McCann SM & Haberland P (1959). Relative abundance of vasopressin and corticotrophin-releasmg factor in neurohypophyseal extracts. Proceedings of the Society for Experimental Biology and Medicine, 102: 319-325.
10. Dhariwal APS, Antunes-Rodrigues J, Reeser F, Chowers I & McCann SM (1966). Purification of hypothalamic corticotrophin-releasing factor of ov ne origin. Proceedings of the Society for Experimental Biology and Medicine, 121:8-12.
11. Rivier J, Spiess J & Vale W (1983). Characterization of rat hypothalamic corticotropin-releas ng factor. Proceedings of the National Academy of Sciences, USA, 80: 4851-4855.
12. McCann SM & Ojeda SR (1996). The anterior pituitary and hypothalamus. In: Griffin JE & Ojeda SR (Editors), Textbook of Endocrine Physiology, 3rd edn. Oxford University Press, New York, NY, 101-133.
13. McCann SM, Antunes-Rodrigues J, Nallar R & Valtin H (1966). Pitu tary acrenal function in the absence of vasopressin. Endocrinology, 79: 1058-1064.
14. Yates FE, Russell SM, Dallman MF, Hedge GA, McCann SM & Dhariwal APS (1971). Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor. Endocrinology, 88: 3-15.
15. Gillies GE, Linton EA & Lowry PJ (1982). Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature, 299: 355-357.
16. Hedge GE, Yates MB, Marcus R & Yates FE (1966). Site of action of vasopressin in causing corticotropin release. Endocrinology, 79: 328-340
17. Ono N, Bedran de Castro JC, Khorram O & McCann SM (1985). Role of arginine vasopressin in control of ACTH and LH release during stress. Life Sciences, 36: 1779-1786.
18. Tilders FJH, Schipper J, Lowry PJ & Vermes I (1982). Effect of hypothalamus lesions on the presence of CRF-immunoreactive nerve terminals in the median eminence and on the pituitary-adrenal response to stress. Regulatory Peptides, 5: 77-84.
19. Gillies G & Lowry PJ (1979). Corticotrophin releasing factor may be modulated by vasopressin. Nature, 278: 463-464.
20. Franci CR, Anselmo-Franci JA & McCann SM (1997). Angiotensinergic neurons physiologically inhibit prolactin, growth hormone, and thyroid-stimulating hormone, but not adrenocorticotropic hormone, release in ovariectomized rats. Peptides, 18: 971-976.
21. Gutkowska J, Antunes-Rodrigues J & McCann SM (1997). Atrial natriuretic peptide in brain and pituitary gland. Physiological Reviews, 77: 465-515.
22. Franci CR, Anselmo-Franci JA & McCann SM (1989). Opposite effects of central immunoneutralization of angiotensin II or atrial natriuretic peptide on luteinizing hormone release in ovariectomized rats. Neuroendocrinology, 51: 683-687.
23. Turnbull A & Rivier C (1996), Corticotropin-releasing factor, vasopressin and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology, 137: 455-463.
24. McCann SM, Fruit A & Fulford BD (1958). Studies on the loci of action of cortical hormones in inhibiting the release of adrenocorticotrophin. Endocrinology, 63: 29-42.
25. Chowers I & McCann SM (1963). The effects on ACTH and gonadotrophin secretion of implants of gonadal steroids in the hypothalamo-hypophysial region. Israel Medical Journal, 22: 420-432.
26. Reichlin S (1992). Neuroendocrinology. In: Foster DE & Wilson JD (Editors), Textbook of Endocrinology. WB Saunders, Philadelphia, 135-220.
27. Goldstein LE, Rasmusson AM, Bunney BS & Roth RH (1996). Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. Journal of Neuroscience, 16: 4787-4798.
28. Arnsten AF, Mathew R, Ubriani R, Taylor JR & Li BM (1999). Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function Biological Psychiatry, 45: 26-31.
29. Anselmo-Franci JA, Rocha-Barros VM, Franci CR & McCann SM (1999). Locus ceruleus lesions block pulsatile LH release in ovariectomized rats. Brain Research, 833: 86-92.
30. Foote SL (1999). Locus coeruleus. In: Adelmar G & Smith BH (Editors), Encyclopedia of Neuroscience. Eisevier, New York, 1062-1063.
31. Bornstein SR & Chrousos GP (1999). Clinical review: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. Journal of Clinical Endocrinology and Metabolism, 84: 1729-1736.
32. Ono N, Bedran de Castro J & McCann SM (1985). Ultrashort-loop positive feedback of corticotropin-releasing factor (CRF) to enhance ACTH release in stress. Proceedings of the National Academy of Sciences, USA, 82: 3528-3531.
33. Ono N, Samson WK, McDonald JK, Lumpkin MD, Bedran de Castro JC & McCann SM (1985). The effects of intravenous and intraventricular injection of antisera directed against corticotropin releasing factor (CRF) on the secretion of anterior pituitary hormones. Proceedings of the National Academy of Sciences, USA, 82: 7787-7790.
34. Ono N, Lumpkin MD, Samson WK, McDonald JK & McCann SM (1984). Intra-hypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growtn hormone and LH release in the rat. Life Sciences, 35: 1117-1123.
35. Rivier C & Vale W (1984). Influence of corticotropin-releasing factor on reproductive functions in the rat Endocrinology, 114: 914-921.
36. Rivier C & Vale W (1984). Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology, 114: 2409-2411.
37. Rettori V, Dees WL, Hiney JK, Lyson K & McCann SM (1994). An interleukin-1-a-pha-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmunomodulation, 1: 251-258.
38. McCann SM (2000). Nitric oxide. In: Fink G (Editor), Encyclopedia of Stress Vol. 3. Academic Press, San Diego, CA, 53-61.
39. Wong M-L, Rettori V, Al-Shekhlee A, Bongiorno PB, Canteros G, McCann SM, Gold PW & Licinio J (1996). Inducible nitric oxide synthase gene expression in the brain during systemic inflammation Nature Medicine, 2: 581-584
40. Banks WA, Kastin AJ, Huang W, Jaspan JB & Maness LM (1996). Leptin enters the brain by a saturable system independent of insulin. Peptides, 17: 305-311.
41. Canteros G, Rettori V, Genaro A, Suburo A, Gimeno M & McCann SM (1996). Nitric oxide synthase content of hypothalamic explants: Increased by norepinephrine and inactivated by NO and cGMP. Proceedings of the National Academy of Sciences, USA, 93: 4246-4250.
42. Wong M-L, Bongiorno PB, Rettori V, McCann SM & Licinio J (1997). Interleukin (IL) 1ß, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications. Proceedings of the National Academy of Sciences, USA, 94: 227-232.
43. McCann SM, Karanth S, Kamat A, Dees WL, Lyson K, Gimeno M & Rettori V (1994). Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation, 1: 2-13.
44. Karanth S, Lyson K & McCann SM (1993). Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proceedings of the National Academy of Sciences, USA, 90: 3383-3387.
45. Karanth S, Lyson K, Aguila MC & McCann SM (1995). Effects of luteinizing-hormone-releasing hormone, α-melanocyte-stimulatmg hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release. Neuroimmunomodulation, 2: 166-173.
46. Lyson K & McCann SM (1992) Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology, 55: 708-713.
47. Karanth S, Lyson K & McCann SM (1994). Cyclosporin A inhibits interleukin-2-induced release of corticotropin releasing hormone. Neuroimmunomodulation, 1: 82-85